·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆʽºÅ¸Å¬·´TVÆʵµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ ¾Ë¸®ÄÚÁ¦¾à "¸ÅÃâ 1677¾ï ½Å±â·Ï¡¦Çö±Ý¹è´ç 20¾ï" ±â»çÀÔ·Â : 23.03.24 20:21:15 0 °¡ ÇÃÄ£Ãß°¡ 32±â Á¤±âÁÖÁÖÃÑȸ °³ÃÖ¡¦Çö±Ý¹è´ç ¹× 6°³ÀÇ ¾È°Ç ÀÇ°á [µ¥Àϸ®ÆÊ=À̼®ÁØ ±âÀÚ] ¾Ë¸®ÄÚÁ¦¾àÀÌ Á¦32±â Á¤±â ÁÖÁÖÃÑȸ¸¦ °³ÃÖÇÏ°í 6°³ ¾È°ÇÀ» ½ÂÀÎÇß´Ù°í 24ÀÏ ¹àÇû´Ù. ȸ»ç´Â ÁÖÁÖÃÑȸ¿¡¼ Áö³ÇØ ¸ÅÃâ¾× 1677¾ï¿ø ´Þ¼º µî ÁÖ¿ä °æ¿µ ½ÇÀûÀ» º¸°íÇß´Ù. °¨»çÀ§¿øȸ ¼³Ä¡¸¦ À§ÇÑ Á¤°ü ÀϺΠ°³Á¤°ú ½Å±Ô »ç¿ÜÀÌ»ç ¹× °¨»çÀ§¿ø ¼±ÀÓ, À̻纸¼öÇѵµ¾× ½ÂÀÎ µî 6°³ ¾È°Çµµ ½ÂÀÎÇß´Ù. ½ÅÀÓ »ç¿ÜÀÌ»ç·Î ¼±ÀÓµÈ À±°æ½Ä È帴 Çѱ¹°øÀÎȸ°è»çȸ »ó±ÙºÎȸÀå ¹× Çѱ¹°øÀÎȸ°è»çȸ °¨¸®Á¶»çÀ§¿øȸ À§¿øÀå µîÀ» ¿ªÀÓÇß´Ù. ½ÃÁø±¹ È帴 ¼¿ïÁß¾ÓÁö¹æ¹ý¿ø ÆÇ»ç ¹× Ã¢¿øÁö¹æ¹ý¿ø Å뿵Áö¿ø ºÎÀåÆÇ»ç µîÀ» Áö³Â´Ù. ÀÌÇ×±¸ ´ëÇ¥ÀÌ»ç´Â "¾Ë¸®ÄÚÁ¦¾àÀº 3³â°£ Äڷγª Ææµ¥¹Í¿¡µµ À̸¦ ±Øº¹ÇÏ°í ÃÖ°í ¸ÅÃâÀ» ´Þ¼ºÇÒ ¼ö ÀÖ¾ú´Ù. ¸ðµç ÀÓÁ÷¿øÀÌ ³ë·ÂÇÑ ¼º°ú"¶ó°í ¸»Çß´Ù. ÇÑÆí ¾Ë¸®ÄÚÁ¦¾àÀº º¸ÅëÁÖ 1ÁÖ´ç 130¿øÀÇ Çö±Ý¹è´çµµ ÀÇ°áÇß´Ù. 20¾ï¿ø ±Ô¸ð´Ù. À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç ±¹Á¦¾àÇ°(ÁÖ) Ç°Áú°ü¸®Ã¥ÀÓ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â [Çѱ¹¿ÀÃ÷Ä«Á¦¾à] º´¿ø¿µ¾÷ ä¿ë¿¬°èÇü ÀÎÅÏ(½ÅÀÔ) ¸ðÁý ¹Ù·Î°¡±â Product Manager (Á¤±ÔÁ÷) ¹Ù·Î°¡±â [»ï¿ø¾àÇ° ¿ï»êÁöÁ¡] °ü¸®¾à»ç´Ô ¸ðÁý°ø°í ¹Ù·Î°¡±â Á¦Á¶°ü¸® ¾à»ç ¸ðÁý ¹Ù·Î°¡±â MSL / ºòµ¥ÀÌÅÍ / ITº¸¾È / °ø¹« / ±â¼ú±³Á¤ / »ý»ê / SFE ¹Ù·Î°¡±â ¼öÀÔ°ü¸®ÀÚ ¾à»ç ¸ðÁý ¹Ù·Î°¡±â PV(¾à¹°°¨½Ã) & RA(ÀÎÇã°¡) ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ(¾à»ç), PV(¾à¹°°¨½Ã) ¹Ù·Î°¡±â °æ·ÂÁ÷ MRä¿ë (¼öµµ±Ç) ¹Ù·Î°¡±â Çѱ¹·Î½´ Clinical Operations Lead ¹Ù·Î°¡±â Clinical Trial Monitor ¹Ù·Î°¡±â »ç¾÷(º»)ºÎº°(CS ¾à»ç ºÎ¹® µî) ä¿ë ¹Ù·Î°¡±â [CSL Behring] ȯÀÚ¼Ö·ç¼Ç ¹× ´ë¿ÜÇù·Â(Sr. Manager) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ¾Ë¸®ÄÚÁ¦¾à ¸ÅÃâ 1677¾ï ½Å±â·Ï¡¦Çö±Ý¹è´ç 20¾ï URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ¾Ë¸®ÄÚÁ¦¾à "¸ÅÃâ 1677¾ï ½Å±â·Ï¡¦Çö±Ý¹è´ç 20¾ï" ±â»çÀÔ·Â : 23.03.24 20:21:15 0 °¡ ÇÃÄ£Ãß°¡ 32±â Á¤±âÁÖÁÖÃÑȸ °³ÃÖ¡¦Çö±Ý¹è´ç ¹× 6°³ÀÇ ¾È°Ç ÀÇ°á [µ¥Àϸ®ÆÊ=À̼®ÁØ ±âÀÚ] ¾Ë¸®ÄÚÁ¦¾àÀÌ Á¦32±â Á¤±â ÁÖÁÖÃÑȸ¸¦ °³ÃÖÇÏ°í 6°³ ¾È°ÇÀ» ½ÂÀÎÇß´Ù°í 24ÀÏ ¹àÇû´Ù. ȸ»ç´Â ÁÖÁÖÃÑȸ¿¡¼ Áö³ÇØ ¸ÅÃâ¾× 1677¾ï¿ø ´Þ¼º µî ÁÖ¿ä °æ¿µ ½ÇÀûÀ» º¸°íÇß´Ù. °¨»çÀ§¿øȸ ¼³Ä¡¸¦ À§ÇÑ Á¤°ü ÀϺΠ°³Á¤°ú ½Å±Ô »ç¿ÜÀÌ»ç ¹× °¨»çÀ§¿ø ¼±ÀÓ, À̻纸¼öÇѵµ¾× ½ÂÀÎ µî 6°³ ¾È°Çµµ ½ÂÀÎÇß´Ù. ½ÅÀÓ »ç¿ÜÀÌ»ç·Î ¼±ÀÓµÈ À±°æ½Ä È帴 Çѱ¹°øÀÎȸ°è»çȸ »ó±ÙºÎȸÀå ¹× Çѱ¹°øÀÎȸ°è»çȸ °¨¸®Á¶»çÀ§¿øȸ À§¿øÀå µîÀ» ¿ªÀÓÇß´Ù. ½ÃÁø±¹ È帴 ¼¿ïÁß¾ÓÁö¹æ¹ý¿ø ÆÇ»ç ¹× Ã¢¿øÁö¹æ¹ý¿ø Å뿵Áö¿ø ºÎÀåÆÇ»ç µîÀ» Áö³Â´Ù. ÀÌÇ×±¸ ´ëÇ¥ÀÌ»ç´Â "¾Ë¸®ÄÚÁ¦¾àÀº 3³â°£ Äڷγª Ææµ¥¹Í¿¡µµ À̸¦ ±Øº¹ÇÏ°í ÃÖ°í ¸ÅÃâÀ» ´Þ¼ºÇÒ ¼ö ÀÖ¾ú´Ù. ¸ðµç ÀÓÁ÷¿øÀÌ ³ë·ÂÇÑ ¼º°ú"¶ó°í ¸»Çß´Ù. ÇÑÆí ¾Ë¸®ÄÚÁ¦¾àÀº º¸ÅëÁÖ 1ÁÖ´ç 130¿øÀÇ Çö±Ý¹è´çµµ ÀÇ°áÇß´Ù. 20¾ï¿ø ±Ô¸ð´Ù. À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç ±¹Á¦¾àÇ°(ÁÖ) Ç°Áú°ü¸®Ã¥ÀÓ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â [Çѱ¹¿ÀÃ÷Ä«Á¦¾à] º´¿ø¿µ¾÷ ä¿ë¿¬°èÇü ÀÎÅÏ(½ÅÀÔ) ¸ðÁý ¹Ù·Î°¡±â Product Manager (Á¤±ÔÁ÷) ¹Ù·Î°¡±â [»ï¿ø¾àÇ° ¿ï»êÁöÁ¡] °ü¸®¾à»ç´Ô ¸ðÁý°ø°í ¹Ù·Î°¡±â Á¦Á¶°ü¸® ¾à»ç ¸ðÁý ¹Ù·Î°¡±â MSL / ºòµ¥ÀÌÅÍ / ITº¸¾È / °ø¹« / ±â¼ú±³Á¤ / »ý»ê / SFE ¹Ù·Î°¡±â ¼öÀÔ°ü¸®ÀÚ ¾à»ç ¸ðÁý ¹Ù·Î°¡±â PV(¾à¹°°¨½Ã) & RA(ÀÎÇã°¡) ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ(¾à»ç), PV(¾à¹°°¨½Ã) ¹Ù·Î°¡±â °æ·ÂÁ÷ MRä¿ë (¼öµµ±Ç) ¹Ù·Î°¡±â Çѱ¹·Î½´ Clinical Operations Lead ¹Ù·Î°¡±â Clinical Trial Monitor ¹Ù·Î°¡±â »ç¾÷(º»)ºÎº°(CS ¾à»ç ºÎ¹® µî) ä¿ë ¹Ù·Î°¡±â [CSL Behring] ȯÀÚ¼Ö·ç¼Ç ¹× ´ë¿ÜÇù·Â(Sr. Manager) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ¾Ë¸®ÄÚÁ¦¾à ¸ÅÃâ 1677¾ï ½Å±â·Ï¡¦Çö±Ý¹è´ç 20¾ï URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ¾Ë¸®ÄÚÁ¦¾à "¸ÅÃâ 1677¾ï ½Å±â·Ï¡¦Çö±Ý¹è´ç 20¾ï" ±â»çÀÔ·Â : 23.03.24 20:21:15 0 °¡ ÇÃÄ£Ãß°¡ 32±â Á¤±âÁÖÁÖÃÑȸ °³ÃÖ¡¦Çö±Ý¹è´ç ¹× 6°³ÀÇ ¾È°Ç ÀÇ°á [µ¥Àϸ®ÆÊ=À̼®ÁØ ±âÀÚ] ¾Ë¸®ÄÚÁ¦¾àÀÌ Á¦32±â Á¤±â ÁÖÁÖÃÑȸ¸¦ °³ÃÖÇÏ°í 6°³ ¾È°ÇÀ» ½ÂÀÎÇß´Ù°í 24ÀÏ ¹àÇû´Ù. ȸ»ç´Â ÁÖÁÖÃÑȸ¿¡¼ Áö³ÇØ ¸ÅÃâ¾× 1677¾ï¿ø ´Þ¼º µî ÁÖ¿ä °æ¿µ ½ÇÀûÀ» º¸°íÇß´Ù. °¨»çÀ§¿øȸ ¼³Ä¡¸¦ À§ÇÑ Á¤°ü ÀϺΠ°³Á¤°ú ½Å±Ô »ç¿ÜÀÌ»ç ¹× °¨»çÀ§¿ø ¼±ÀÓ, À̻纸¼öÇѵµ¾× ½ÂÀÎ µî 6°³ ¾È°Çµµ ½ÂÀÎÇß´Ù. ½ÅÀÓ »ç¿ÜÀÌ»ç·Î ¼±ÀÓµÈ À±°æ½Ä È帴 Çѱ¹°øÀÎȸ°è»çȸ »ó±ÙºÎȸÀå ¹× Çѱ¹°øÀÎȸ°è»çȸ °¨¸®Á¶»çÀ§¿øȸ À§¿øÀå µîÀ» ¿ªÀÓÇß´Ù. ½ÃÁø±¹ È帴 ¼¿ïÁß¾ÓÁö¹æ¹ý¿ø ÆÇ»ç ¹× Ã¢¿øÁö¹æ¹ý¿ø Å뿵Áö¿ø ºÎÀåÆÇ»ç µîÀ» Áö³Â´Ù. ÀÌÇ×±¸ ´ëÇ¥ÀÌ»ç´Â "¾Ë¸®ÄÚÁ¦¾àÀº 3³â°£ Äڷγª Ææµ¥¹Í¿¡µµ À̸¦ ±Øº¹ÇÏ°í ÃÖ°í ¸ÅÃâÀ» ´Þ¼ºÇÒ ¼ö ÀÖ¾ú´Ù. ¸ðµç ÀÓÁ÷¿øÀÌ ³ë·ÂÇÑ ¼º°ú"¶ó°í ¸»Çß´Ù. ÇÑÆí ¾Ë¸®ÄÚÁ¦¾àÀº º¸ÅëÁÖ 1ÁÖ´ç 130¿øÀÇ Çö±Ý¹è´çµµ ÀÇ°áÇß´Ù. 20¾ï¿ø ±Ô¸ð´Ù. À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ¾Ë¸®ÄÚÁ¦¾à ¸ÅÃâ 1677¾ï ½Å±â·Ï¡¦Çö±Ý¹è´ç 20¾ï URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö